Fluoxetine potentiation by buspirone : three case historiesBAKISH, D.Canadian journal of psychiatry. 1991, Vol 36, Num 10, pp 749-750, issn 0706-7437Article

The patient with comorbid depression and anxiety : The unmet needBAKISH, D.The Journal of clinical psychiatry. Supplement. 1999, Vol 60, Num 6, pp 20-24Conference Paper

Disulfiram and bipolar affective disorder: a case reportBAKISH, D; LAPIERRE, Y. D.Journal of clinical psychopharmacology. 1986, Vol 6, Num 3, pp 178-180, issn 0271-0749Article

An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorderHOOPER, C. L; BAKISH, D.Journal of psychiatry & neuroscience. 2000, Vol 25, Num 2, pp 178-184, issn 1180-4882Article

Combined SSRI-moclobemide treatment of psychiatric illnessJOFFE, R. T; BAKISH, D.The Journal of clinical psychiatry. 1994, Vol 55, Num 1, pp 24-25, issn 0160-6689Article

Brainstem evoked potentials in panic disorderKNOTT, V. J; BAKISH, D; BARKLEY, J et al.Journal of psychiatry & neuroscience. 1994, Vol 19, Num 4, pp 301-306, issn 1180-4882Article

Mixed anxiety and depression : Diagnosis and treatment optionsBAKISH, D; HABIB, R; HOOPER, C. L et al.CNS drugs. 1998, Vol 9, Num 4, pp 271-280, issn 1172-7047Article

Relaxation-induced EEG alterations in panic disorder patientsKNOTT, V; BAKISH, D; LUSK, S et al.Journal of anxiety disorders. 1997, Vol 11, Num 4, pp 365-376, issn 0887-6185Article

Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depressionOWEN, D; LISHENG DU; BAKISH, D et al.Psychiatry research. 1999, Vol 87, Num 1, pp 1-5, issn 0165-1781Article

A dose-finding study with remoxipride in the acute treatment of schizophrenic patientsLAPIERRE, Y. D; ANCILL, R; HORN, E et al.Journal of psychiatry & neuroscience. 1992, Vol 17, Num 4, pp 134-145, issn 1180-4882, 11 p.Article

Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder : examination from a duloxetine, venlafaxine extended-release and placebo-controlled trialNICOLINI, H; BAKISH, D; DUENAS, H et al.Psychological medicine (Print). 2009, Vol 39, Num 2, pp 267-276, issn 0033-2917, 10 p.Article

Fast onset : an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapyBAKISH, D; HOOPER, C. L; THORNTON, M. D et al.International clinical psychopharmacology. 1997, Vol 12, Num 2, pp 91-97, issn 0268-1315Article

Reversible monoamine oxidase-A inhibitors in panic disorderBAKISH, D; SAXENA, B. M; BOWEN, R et al.Clinical neuropharmacology. 1993, Vol 16, pp S77-S82, issn 0362-5664, SUP2Conference Paper

Reduction in suicidal ideation with SSRIs: a review of 459 depressed patientsFILTEAU, M.-J; LAPIERRE, Y. D; BAKISH, D et al.Journal of psychiatry & neuroscience. 1993, Vol 18, Num 3, pp 114-119, issn 1180-4882Article

Preparatory brain potentials in major depressive disorderKNOTT, V. J; LAPIERRE, Y. D; DE LUGT, D et al.Progress in neuro-psychopharmacology & biological psychiatry. 1991, Vol 15, Num 2, pp 257-262, issn 0278-5846, 6 p.Conference Paper

Venlafaxine in treatment-resistant major depression : A Canadian multicenter, open-label trialDE MONTIGNY, C; SILVERSTONE, P. H; DEBONNEL, G et al.Journal of clinical psychopharmacology. 1999, Vol 19, Num 5, pp 401-406, issn 0271-0749Article

Platelet serotonergic indices in major depression : up-regulation of 5-HT_2A receptors unchanged by antidepressant treatmentHRDINA, P. D; BAKISH, D; RAVINDRAN, A et al.Psychiatry research. 1997, Vol 66, Num 2-3, pp 73-85, issn 0165-1781Article

Ritanserin, imipramine, and placebo in the treatment of dysthymic disorderBAKISH, D; LAPIERRE, Y. D; THIBAUDEAU, C et al.Journal of clinical psychopharmacology. 1993, Vol 13, Num 6, pp 409-414, issn 0271-0749Article

Event-related potentials and selective attention in major depressive illnessKNOTT, V; LAPIERRE, Y; GRIFFITHS, L et al.Journal of affective disorders. 1991, Vol 23, Num 1, pp 43-48, issn 0165-0327Article

Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepinHRDINA, P. D; BAKISH, D; SWENSON, S et al.Therapeutic drug monitoring. 1990, Vol 12, Num 2, pp 129-133, issn 0163-4356Article

Quantitative EEG correlates of panic disorderKNOTT, V. J; BAKISH, D; LUSK, S et al.Psychiatry research. 1996, Vol 68, Num 1, pp 31-39, issn 0165-1781Article

A comparison of placebo responders and nonresponders in subgroups of depressive disorderBIALIK, R. J; RAVINDRAN, A. V; BAKISH, D et al.Journal of psychiatry & neuroscience. 1995, Vol 20, Num 4, pp 265-270, issn 1180-4882Article

A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depressionCHOUINARD, G; SAXENA, B. M; BELANGER, M. C et al.Journal of affective disorders. 1994, Vol 32, Num 2, pp 105-114, issn 0165-0327Article

Dysthymia and serotoninLAPIERRE, Y. D; RAVINDRAN, A; BAKISH, D et al.International clinical psychopharmacology. 1993, Vol 8, pp 87-90, issn 0268-1315, SUP2Conference Paper

A comparison of moclobemide, amitriptyline and placebo in depression : a Canadian multicentre studyBAKISH, D; BRADWEJN, J; NAIR, N et al.Psychopharmacologia. 1992, Vol 106, pp S98-S101, issn 0033-3158, SUPConference Paper